Back to Journals » ImmunoTargets and Therapy » Volume 7
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (174)
- Volume 13, 2024 (19)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 7, 2018
Immunological targets for cancer therapy: new recognition
Shurin MR
ImmunoTargets and Therapy 2018, 7:83-85
Published Date: 21 November 2018
Alteration of gene expression profile in CD3+ T-cells after downregulating MALT1
Wang X, Lu S, Xiao Y, Xu L, Zhou L, Hu JY, Li B, Zeng C, Li Y
ImmunoTargets and Therapy 2018, 7:77-81
Published Date: 20 November 2018
Review of checkpoint immunotherapy for the management of non-small cell lung cancer
Raju S, Joseph R, Sehgal S
ImmunoTargets and Therapy 2018, 7:63-75
Published Date: 31 July 2018
Multiple effects of CD40–CD40L axis in immunity against infection and cancer
Ara A, Ahmed KA, Xiang J
ImmunoTargets and Therapy 2018, 7:55-61
Published Date: 28 June 2018
Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer
Zohar DN, Shoenfeld Y
ImmunoTargets and Therapy 2018, 7:51-53
Published Date: 22 June 2018
Melanoma treatment in review
Domingues B, Lopes JM, Soares P, Pópulo H
ImmunoTargets and Therapy 2018, 7:35-49
Published Date: 7 June 2018
William Bradley Coley, MD, and the phenomenon of spontaneous regression
Vernon LF
ImmunoTargets and Therapy 2018, 7:29-34
Published Date: 23 April 2018
Oncogenes in immune cells as potential therapeutic targets
Zakiryanova GK, Wheeler S, Shurin MR
ImmunoTargets and Therapy 2018, 7:21-28
Published Date: 11 April 2018
Immunotherapy in Merkel cell carcinoma: role of Avelumab
Palla AR, Doll D
ImmunoTargets and Therapy 2018, 7:15-19
Published Date: 2 March 2018
Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
Belzile O, Huang X, Gong J, Carlson J, Schroit AJ, Brekken RA, Freimark BD
ImmunoTargets and Therapy 2018, 7:1-14
Published Date: 23 January 2018